Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals
ALNY | NASDAQ
Chart Builder DCF Calculator
$159.73
-$5.31 (-3.22%)
At close: Nov 16, 2026, 4:00 PM ET
$159.00
-$0.73 (-0.46%)
Pre-market: Nov 17, 2026, 4:17 AM ET

Alnylam Pharmaceuticals Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
313.75M -278.16M -440.24M -1.13B -852.82M -858.28M
55.66M 56.67M 54.05M 44.47M 47.57M 74.44M
348.24M 272.08M 221.68M 230.65M 165.72M 139.87M
-168.36M -232.22M -509K -147.59M -122.85M -38.42M
253.42M 261.94M 257.91M 350.32M 216.37M 95.76M
-2.2M -106.76M – – -55.7M -54.04M
-444.78M -214.08M 10.76M -35.55M -162.82M -12.7M
524.08M -8.31M 104.16M -541.27M -641.69M -614.96M
-58.7M -34.28M -62.21M -72.06M -76.37M -70.36M
– – – – – –
-1.36B -1.71B -1.82B -1.98B -1.66B -2.03B
1.8B 1.57B 1.55B 2.23B 1.46B 1.69B
57.63M 57.76M -4.44M -13.19M -4.36M -31.2M
436.33M -116.84M -336.35M 169.35M -273.3M -435.52M
-546.95M – – 254M 500M 200M
– – – – – –
– – – – – –
-8.27M -8.79M 24.67M -87.61M 500.85M 695.48M
-305.19M 294.16M 172.13M 425.75M 1.25B 994.98M
690.16M 153.77M -53.67M 46.4M 323.11M -50.58M
465.38M -42.59M 41.95M -613.33M -718.07M -685.32M
117.15M -314.67M -179.74M -843.98M -883.78M -825.2M
– – – – – –
-58.7M -34.28M -62.21M -72.06M -76.37M -70.36M
524.08M -8.31M 104.16M -541.27M -641.69M -614.96M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.